Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
SEGMENT INFORMATION  
Schedule of segment information

Three Months Ended September 30, 

Nine Months Ended September 30, 

2025

2024

 

2025

2024

(in thousands)

(in thousands)

Total Revenues

$

69,462

$

55,307

$

224,480

$

121,682

Less:

Employee related expenses

18,547

16,104

56,666

52,552

Commercial related expenses

6,303

6,768

18,915

19,002

Outside clinical trial related expenses

3,759

3,303

11,362

8,183

Cost of product sales

4,753

8,026

13,666

12,859

Consultants and third-party services

4,133

3,476

10,751

11,851

Other segment items

3,547

3,574

10,824

9,698

Interest expense, net

800

1,635

3,183

4,393

(Benefit from) provision for income taxes

(280)

154

Segment income

$

27,900

$

12,421

$

98,959

$

3,144